Literature DB >> 8832894

Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53.

M F Denissenko1, A Pao, M Tang, G P Pfeifer.   

Abstract

Cigarette smoke carcinogens such as benzo[a]pyrene are implicated in the development of lung cancer. The distribution of benzo[a]pyrene diol epoxide (BPDE) adducts along exons of the P53 gene in BPDE-treated HeLa cells and bronchial epithelial cells was mapped at nucleotide resolution. Strong and selective adduct formation occurred at guanine positions in codons 157, 248, and 273. These same positions are the major mutational hotspots in human lung cancers. Thus, targeted adduct formation rather than phenotypic selection appears to shape the P53 mutational spectrum in lung cancer. These results provide a direct etiological link between a defined chemical carcinogen and human cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8832894     DOI: 10.1126/science.274.5286.430

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  302 in total

Review 1.  Soft tissue sarcomas and p53 mutations.

Authors:  H Taubert; A Meye; P Würl
Journal:  Mol Med       Date:  1998-06       Impact factor: 6.354

Review 2.  Molecular genetic abnormalities in the pathogenesis of human lung cancer.

Authors:  E Forgacs; S Zöchbauer-Müller; E Oláh; J D Minna
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

3.  Mutation frequencies at codon 248 of the p53 tumour suppressor gene are not increased in colon cancer cell lines with the RER+ phenotype.

Authors:  T Mancuso; F Aguilar; M P Pescarolo; L Clerico; P Russo; S Parodi
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

Review 4.  An evolutionary paradigm for carcinogenesis?

Authors:  P Vineis; G Matullo; M Manuguerra
Journal:  J Epidemiol Community Health       Date:  2003-02       Impact factor: 3.710

5.  How many mutant p53 molecules are needed to inactivate a tetramer?

Authors:  Wan Mui Chan; Wai Yi Siu; Anita Lau; Randy Y C Poon
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 6.  Genetic changes in squamous cell lung cancer: a review.

Authors:  Rebecca S Heist; Lecia V Sequist; Jeffrey A Engelman
Journal:  J Thorac Oncol       Date:  2012-05       Impact factor: 15.609

7.  Synergistic effects of NAT2 slow and GSTM1 null genotypes on carcinogen DNA damage in the lung.

Authors:  Mi-Sun Lee; Li Su; David C Christiani
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

Review 8.  Epigenetics of lung cancer.

Authors:  Scott M Langevin; Robert A Kratzke; Karl T Kelsey
Journal:  Transl Res       Date:  2014-03-12       Impact factor: 7.012

Review 9.  Polycyclic aromatic hydrocarbons: from metabolism to lung cancer.

Authors:  Bhagavatula Moorthy; Chun Chu; Danielle J Carlin
Journal:  Toxicol Sci       Date:  2015-05       Impact factor: 4.849

10.  Structure of DNA polymerase beta with a benzo[c]phenanthrene diol epoxide-adducted template exhibits mutagenic features.

Authors:  Vinod K Batra; David D Shock; Rajendra Prasad; William A Beard; Esther W Hou; Lars C Pedersen; Jane M Sayer; Haruhiko Yagi; Subodh Kumar; Donald M Jerina; Samuel H Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.